SCHEMBL14958433

SCHEMBL14958433

CC(C)Cn1cnc2c(N(C)CC(=O)O)nc3ccccc3c21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 7/20 0.60
PDE4D Q08499 2/20 0.60
LMNA P02545 1/20 0.60
POLB P06746 1/20 0.60
HRH2 P25021 1/20 0.60
ADRA1D P25100 1/20 0.60
HTR2A P28223 1/20 0.60
ADORA2A P29274 1/20 0.60
ADRA1A P35348 1/20 0.60
NUDT1 P36639 1/20 0.60
HTR2B P41595 1/20 0.60
KCNH2 Q12809 1/20 0.60
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
APAF1 O14727 1/20 0.39
OGFRL1 Q5TC84 1/20 0.37
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14957867 0.86 MAOB (0.45) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL822915 0.85 TLR7 (0.69) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL14958435 0.84 NPC1 (0.43) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL18477815 0.82 TLR7 (0.59) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL7832281 0.79 TLR7 (0.63) TLR7PDE4DLMNAPOLBHRH2
Propionic Acid SCHEMBL9388385 0.79 TLR7 (0.63) TLR7PDE4DLMNAPOLBHRH2
Propionic Acid SCHEMBL6719538 0.78 TLR7 (0.62) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL4830500 0.78 TLR7 (0.72) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL29376434 0.78 TLR7 (0.72) TLR7PDE4DLMNAPOLBHRH2
SCHEMBL487883 0.77 TLR7 (0.68) TLR7PDE4DLMNAPOLBHRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9567329-B2 High penetration prodrug compositions of 1H-imidazo[4,5-c]quinolin-4-amines and 1H-imidazo[4,5-c]quinolin-4-amine-related compounds and uses thereof TECHFIELDS PHARMA CO., LTD. (CN) 2017-02-14 US disclosed
US-20130131100-A1 HIGH PENETRATION PRODRUG COMPOSITIONS OF 1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINES AND 1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINE-RELATED COMPOUNDS AND USES THEREOF PREMIER RESEARCH INTERNATIONAL, LLC 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131100-A1 HIGH PENETRATION PRODRUG COMPOSITIONS OF 1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINES AND 1H-IMIDAZO[4,5-C]QUINOLIN-4-AMINE-RELATED COMPOUNDS AND USES THEREOF HRH4, SLC7A1, ABCG2 TLR7 1432/4885PDE4D 747/4885LMNA 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.